PEDIATRIC DIABETES RESEARCH CENTER

Clinical Research

There are multiple ongoing clinical trials in patients with new onset of type 1 diabetes. The overall aim of these trials is to identify a means of blocking further autoimmune destruction of the beta cells. Eventually, this therapy may also be used at an even earlier stage to prevent type 1 diabetes.

The PDRC also participates in two landmark studies: the Type 1 Diabetes Exchange and the TrialNet Natural History Study. Both studies offer clinicians and researchers the opportunity to learn more about treatment outcomes of patients with type 1 diabetes and the incidence of type 1 diabetes in family members at high risk of developing diabetes.

Our investigators also conduct clinical trials for patients with type 2diabetes. These trials will help increase therapy options for type 2 diabetes patients under the age of 18.

The use of technology in the management of diabetes and obesity in pediatric patients has become a recent focus of clinical investigation. Presently we are evaluating the use of glucose meters with built in wireless communication to promote diabetes self-management and facilitate communication between the patient’s family and health care team.

Recruitment Contact:
Marla Hashiguchi, RN
Phone: (858) 966-8940
mhashiguchi@rchsd.org

Type 1 Diabetes Clinical Trials

  • Combination Therapy with Sitagliptin (DPP-4 Inhibitor) and Lansoprazole (Proton Pump Inhibitor) to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
  • Protocol: Repair- T1D
  • Automated Glucose Monitoring in Children and Adolescents with Type 1 Diabetes Mellitus
  • Immune homeostasis and mechanisms of disease progression in children with newly diagnosed type 1 diabetes
  • Type 1 Diabetes Exchange
  • TrialNet Natural History Study

For more information on our Type 1 Diabetes clinical trials and studies, please visit our Type 1 Clinical Trials page.

Type 2 Diabetes Clinical Trials


For more information on our Type 2 Diabetes clinical trials and studies, please visit our Type 2 Clinical Trials page.